| Role of baseline leptin and ghrelin levels on body weight and fat mass changes after an energy-restricted diet intervention in obese women: effects on energy metabolism. | |
| | |
MedLine Citation:
|
PMID: 21470990 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
CONTEXT: Hormones related to energy balance control may play an important role on weight loss resistance after low-caloric diet (LCD) intervention. OBJECTIVE: To investigate the predictive value of baseline leptin and ghrelin on body fat mass (FM) loss after 12 wk of LCD intervention and to study whether these associations could be related to changes in resting metabolic rate (RMR). DESIGN: The study comprised a total of 78 obese women (age 36.7 ± 7 yr). We measured, before and after the LCD intervention, FM (dual-energy x-ray absorptiometry) and RMR (kilojoules per kilogram body weight per day, indirect calorimetry). We also analyzed fasting serum leptin and ghrelin, and leptin to ghrelin ratio was calculated. MAIN OUTCOME MEASURES: FM and RMR changes (data at baseline - data after the intervention) were assessed. RESULTS: Baseline serum leptin (r = -0.301; age- and baseline FM-adjusted P = 0.009) and ghrelin (r = 0.314, adjusted P = 0.014) levels as well as leptin to ghrelin levels (r = -0.331; adjusted P = 0.009) were significantly correlated with FM changes. Leptin to ghrelin ratio was significantly correlated with RMR at baseline and after the LCD (both P < 0.010). Baseline leptin to ghrelin ratio significantly predicted changes in RMR after the LCD (r = 0.298; P = 0.019) regardless of age, baseline RMR, and total body weight (r = 0.307; P = 0.016) or FM loss (r = 0.312; P = 0.015). CONCLUSIONS: Obese women with higher leptin and lower ghrelin levels at baseline seem to be more resistant to FM loss. The leptin to ghrelin ratio could be proposed as a biomarker for predicting metabolic adaptations to energy restriction treatment and, if confirmed in future studies, as a predictor of treatment success/failure. |
| | |
Authors:
|
Idoia Labayen; Francisco B Ortega; Jonatan R Ruiz; Arrate Lasa; Edurne Simón; Javier Margareto |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2011-04-06 |
Journal Detail:
|
Title: The Journal of clinical endocrinology and metabolism Volume: 96 ISSN: 1945-7197 ISO Abbreviation: J. Clin. Endocrinol. Metab. Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-05-23 Completed Date: 2011-08-05 Revised Date: 2012-05-29 |
Medline Journal Info:
|
Nlm Unique ID: 0375362 Medline TA: J Clin Endocrinol Metab Country: United States |
Other Details:
|
Languages: eng Pagination: E996-1000 Citation Subset: AIM; IM |
Affiliation:
|
Department of Nutrition and Food Science, University of the Basque Country, Paseo de la Universidad, 7.01006 Vitoria, Spain. idoia.labayen@ehu.es |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Absorptiometry, Photon Adipose Tissue / metabolism* Adult Body Composition / physiology Body Weight / physiology* Calorimetry, Indirect Diet, Reducing* Energy Metabolism / physiology* Female Ghrelin / blood* Humans Leptin / blood* Middle Aged Obesity / diet therapy*, metabolism* |
| Chemical | |
Reg. No./Substance:
|
0/Ghrelin; 0/Leptin |
| Comments/Corrections | |
Erratum In:
|
J Clin Endocrinol Metab. 2012 Apr;97(4):1399 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Low Incidence of Adrenal Insufficiency after Transsphenoidal Surgery in Patients with Acromegaly: A ...
Next Document: Plasma Concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as Predictors of Tumor Response to Mitotane i...